Literature DB >> 11340798

Drooling in Parkinson's disease: a novel tool for assessment of swallow frequency.

L Marks1, J Weinreich.   

Abstract

A non-invasive way to obtain objective measurements of swallowing frequency and thus indirectly, drooling was required as part of the study 'Drooling in Parkinson's disease: objective measurement and response to therapy'. A hard disk, digital recorder was developed, for use on a laptop computer, which was capable of collecting large quantities of swallowing data from an anticipated 40 patients and 10 controls. An electric microphone was taped to the subjects' larynx for recording the swallow sounds when drinking 150 ml of water and at rest for 30 minutes. The software provides an accurate visual display of the audio-signal allowing the researcher easy access to any segment of the recording and to mark and extract the swallow events, so that swallow frequency may be efficiently and accurately ascertained. Preliminary results are presented.

Entities:  

Mesh:

Year:  2001        PMID: 11340798     DOI: 10.3109/13682820109177899

Source DB:  PubMed          Journal:  Int J Lang Commun Disord        ISSN: 1368-2822            Impact factor:   3.020


  3 in total

1.  Botulinum toxin: a novel therapy for clozapine-induced sialorrhoea.

Authors:  Rohit Verma; Kuljeet Singh Anand
Journal:  Psychopharmacology (Berl)       Date:  2017-12-01       Impact factor: 4.530

2.  Hypersialorrhea in Wilson's Disease.

Authors:  Jean-Marc Trocello; Karima Osmani; Michaela Pernon; Gérard Chevaillier; Claire de Brugière; Pascal Remy; Emilie Wenisch; Catherine Cousin; Nadège Girardot-Tinant; France Woimant
Journal:  Dysphagia       Date:  2015-07-25       Impact factor: 3.438

Review 3.  Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.

Authors:  Marian L Evatt; K Ray Chaudhuri; Kelvin L Chou; Ester Cubo; Vanessa Hinson; Katie Kompoliti; Chengwu Yang; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2009-04-15       Impact factor: 10.338

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.